Zobrazeno 1 - 10
of 21
pro vyhledávání: '"AL. A. Sergeev"'
Autor:
A. G. Poltavchenko, A. V. Ersh, P. V. Filatov, N. D. Ushkalenko, S. N. Yakubitsky, Al. A. Sergeev, D. N. Shcherbakov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 106-113 (2021)
The aim of the study was to develop a sensitive and fast immunochemical test for the detection of orthopoxviruses (OPXV) in the “point of care” format.Materials and methods. The analyses were performed in cultured crude and purifed preparations o
Externí odkaz:
https://doaj.org/article/a04b7b50f87a4546a043ee09d4db26cf
Autor:
O. K. Demina, A. A. Sergeev, A. P. Agafonov, A. N. Shikov, A. O. Sementsova, AL. A. Sergeev, A. N. Sergeev, I. G. Drozdov
Publikováno v:
Антибиотики и Химиотерапия, Vol 54, Iss 9-10, Pp 27-29 (2020)
The efficacy of the therapeutic, prophylactic and urgent prophylactic schemes for the use of Reaferon-ES lipint®, a liposomal human recombinant α-interferon for oral use, was studied on mice infected with the avian influenza virus. Strain A/Chicken
Externí odkaz:
https://doaj.org/article/2b1b96f23d42441ab84568d976e644a5
Autor:
A. I. Terent’ev, V. A. Zhukov, Ar. A. Sergeev, S. B. Pastushenko, S. V. Rоgоzhkina, S. V. Borisevich, V. A. Maksimov, Al. A. Sergeev, K. A. Titova, D. O. Galakhova
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 94-99 (2019)
Objective of the work was the production of recombinant vaccine «RevaxVZT» in tablet dosage form against hepatitis B and pathogenic for humans orthopoxviruses for further clinical trials. Materials and methods. Recombinant strain b7.5S2-S of vaccin
Externí odkaz:
https://doaj.org/article/82caec297f4545c59d859c44a9ba1362
Autor:
A. S. Zamedyanskaya, Al. A. Sergeev, K. A. Titova, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, A. E. Nesterov, O. V. Nosareva, D. O. Galakhova, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 75-78 (2016)
Objective of the study is to investigate the sensitivity of different animals to highly pathogenic Orthopoxviruses applying techniques, based on utilization of primary cultures of lung cells, and to assess the possibility of further deployment of thi
Externí odkaz:
https://doaj.org/article/dd9f597aece14c038df1adf618d2cad7
Autor:
D. O. Galakhova, Ar. A. Sergeev, E. V. Shevtsova, Al. A. Sergeev, A. S. Zamedyanskaya, K. A. Titova, L. N. Shishkina, L. E. Bulychev, S. V. Borisevich, V. N. Podkuiko, A. P. Pirozhkov, A. V. Koval’Chuk, Ya. V. Polyansky, E. Yu. Vakhnov, V. V. Perekrest, V. A. Shevtsov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 84-89 (2016)
Objective of the investigation was to model the adverse action of vaccinia virus (VV), caused by oral immunization of mice and to evaluate efficacy of its reduction, using therapeutic and prophylactic drugs. Materials and methods. Virological and imm
Externí odkaz:
https://doaj.org/article/2f2e4a61775149329dc1cadbb24582a5
Autor:
K. A. Titova, Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, D. O. Galahova, A. S. Zamedyanskaya, L. N. Shishkina, O. S. Taranov, V. V. Omigov, E. L. Zavjalov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 19, Iss 4, Pp 487-493 (2015)
At present, there is no animal model for smallpox that reflects the weakened immune system in people and can therefore help assess the prophylactic (highly preventive) efficiency of antiviral drugs. To fill in the gap, we have explored the possibilit
Externí odkaz:
https://doaj.org/article/9bb5088aad6642b2a9041610de31713f
Autor:
Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, O. V. P’Yankov, Ar. A. Sergeev, S. A. Bodnev, D. O. Gorbatovskaya, A. S. Zamedyanskaya, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 4, Pp 86-90 (2015)
By the experiments of in vivo intranasal infection of 8-10-days-old outbread ICR mice with Monkeypox virus (MPV) in a dose equal 3.83 lg FFU/specimen, investigated was dynamics of the virus accumulation within various organs, blood cells, and blood s
Externí odkaz:
https://doaj.org/article/31647faedd1e46d4a264605086d2cff7
Autor:
Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, O. V. P’Yankov, Ar. A. Sergeev, O. S. Taranov, S. A. Bodnev, Yu. V. Tumanov, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2, Pp 60-65 (2013)
of MPV after 7 days postinfection, applying peroral administration once within 24 hours (24 hours before infection and 7 days after infection of mouse with 60 µg/g of a preparation). Displayed is the feasibility of using 8–15-days-old ICR mice (bo
Externí odkaz:
https://doaj.org/article/57e9151a7ab5456cae87a7b636828c92
Autor:
A. S. Kabanov, Al. A. Sergeev, L. E. Bulychev, N. I. Bormotov, L. N. Shishkina, Ar. A. Sergeev, S. A. Bodnev, M. O. Skarnovich, A. R. Shevtsov, B. A. Selivanov, A. Ya. Tikhonov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2, Pp 54-59 (2013)
for ST-246 and NIOC-14 is within the range of 0,001-0,004 µg/ml, and IS for both of them is > 100000. In addition, ST-246 and NIOC-14 chemical compound efficacy, concentrated up to 0,0125; 0,025 and 0,05 µg/ml, in accordance with prophylactic chart
Externí odkaz:
https://doaj.org/article/8945cae60ae645d0a1ef3cc30e4c8e17
Autor:
O. K. Demina, Ar. A. Sergeev, O. V. P'yankov, A. N. Shikov, Al. A. Sergeev, S. A. Berillo, E. I. Sergeeva, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2(112), Pp 65-68 (2012)
Studied was dissemination of avian influenza virus (AIV) in the organism of chickens after intranasal challenge with 10-100 LD50. The primary organ of accumulation of AIV A/H5N1 (A/Chicken/Kurgan/05/2005strain) is the respiratory tract (nasal mucosa)
Externí odkaz:
https://doaj.org/article/f51a337a141842c3ad9a1910e8477c90